SCHEMBL7913446

SCHEMBL7913446

CCOc1nc2ccccc2c(-n2ccnn2)c1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SQOR Q9Y6N5 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPK8 P45983 5/20 0.40
▸ RPS27 P42677 4/20 0.40
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ MAPK9 P45984 4/20 0.38
▸ MAPK10 P53779 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HRH4 Q9H3N8 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ RAD52 P43351 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ SLC2A1 P11166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914421 0.91 ALDH1A1 (0.40) SQORKDM4EALDH1A1MAPK8KMT2A
SCHEMBL7906146 0.81 SQOR (0.47) SQORKDM4EALDH1A1MAPK8RPS27
SCHEMBL7913445 0.80 KDM4E (0.41) SQORKDM4EALDH1A1MAPK8RPS27
SCHEMBL7916403 0.76 ALDH1A1 (0.40) SQORKDM4EALDH1A1MAPK8KMT2A
SCHEMBL7913465 0.76 ALDH1A1 (0.40) SQORKDM4EALDH1A1MAPK8KMT2A
SCHEMBL7914416 0.73 ALDH1A1 (0.40) KDM4EALDH1A1POLBMAPTHPGD
SCHEMBL2871464 0.72 ALDH1A1 (0.42) SQORKDM4EALDH1A1MAPK8RPS27
SCHEMBL7916445 0.72 ALDH1A1 (0.40) SQORKDM4EALDH1A1MAPK8RPS27
SCHEMBL7914410 0.71 ALDH1A1 (0.40) SQORKDM4EALDH1A1MAPK8KMT2A
SCHEMBL20975374 0.67 PDE10A (0.44) KDM4EALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297258-B1 USEFUL AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE. AMERICAN CYANAMID COMPANY 2001-10-02 — — US disclosed
Send feedback